Results 21 to 30 of about 549,379 (280)
Journal of Nanobiotechnology, 2022 Background Although concurrent chemoradiotherapy (CRT), as one of the most effective antineoplastic therapies in clinic, can successfully inhibit the growth of tumor cells, a risk of developing secondary tumor is still an insurmountable barrier in ...
Wei-Zhou Jiang +6 more
semanticscholar +1 more source
JAMA Network Open, 2022 Key Points Question Should concurrent chemoradiotherapy be considered for patients with synchronous oligometastatic esophageal squamous cell carcinoma (SOESCC), and which patients are suitable for early intensive treatment?
Zhenguo Shi +16 more
semanticscholar +1 more source
JAMA Oncology, 2021 Importance Most older patients with esophageal cancer cannot complete the standard concurrent chemoradiotherapy (CCRT). An effective and tolerable chemoradiotherapy regimen for older patients is needed.
Y. Ji +58 more
semanticscholar +1 more source
Frontiers in Oncology, 2023 Background Neoadjuvant chemoradiotherapy is the standard treatment for locally advanced rectal cancer, with modest benefits on tumor regression and survival.
Jiale Gao +16 more
semanticscholar +1 more source
Endoscopic Submucosal Dissection Followed by Concurrent Chemoradiotherapy in Patients with Early Esophageal Cancer with a High Risk of Lymph Node Metastasis [PDF]
Clinical Endoscopy, 2019 Endoscopic submucosal dissection is recommended as an alternative therapy for early esophageal cancer. However, achieving curative resection in this procedure remains controversial since precise prediction of lymph node metastasis can be difficult. Here,
Hee Kyung Kim +7 more
doaj +1 more source
Future Oncology, 2021 Definitive chemoradiotherapy is the standard of care for inoperable locoregionally advanced esophageal squamous cell carcinoma (ESCC). Immune checkpoint inhibitors such as anti-PD-1/PD-L1 antibodies have led to a paradigm shift in advanced, metastatic ...
R. Yu +15 more
semanticscholar +1 more source
Scientific Reports, 2021 Targeted sequencing for somatic mutations across the hotspots of 50 cancer-related genes was performed using biopsy specimens to investigate whether clinicopathological factors and genomic alterations correlated with prognosis in locally advanced ...
I. Kuno +15 more
semanticscholar +1 more source
Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma. [PDF]
PLoS ONE, 2013 BACKGROUND:To evaluate the contribution of chemotherapy for patients with locoregionally advanced nasopharyngeal carcinoma (NPC) treated by intensity modulated radiotherapy (IMRT) and to identify the optimal combination treatment strategy.
Xuemei Ji +5 more
doaj +1 more source
EFFECT OF CONCURRENT CHEMORADIOTHERAPY ON PERIPHERAL BLOOD LYMPHOCYTES, CYTOKINES, AND GUT MICROBIOTA IN PATIENTS WITH PELVIC TUMOR [PDF]
精准医学杂志, 2023 Objective To investigate the effect of concurrent chemoradiotherapy on immune function, inflammatory state, and gut microbiota in patients with pelvic tumor.
LYU Zhuochun, CHEN Xiaohui, QIN Chen, JU Fang
doaj +1 more source
Cancers, 2021 Simple Summary The prognosis of esophageal squamous cell carcinoma (ESCC) patients is poor, with a five-year survival of 15–34%. We examined the expression of STAT3α and STAT3β in pretreatment tumor biopsies of 105 ESCC patients who received concurrent ...
Zhenyu Zheng +13 more
semanticscholar +1 more source